Producing IP-10 with Lactococcus lactis
Author Information
Author(s): Julio Villatoro-Hernandez, Maria J Loera-Arias, Anali Gamez-Escobedo, Moises Franco-Molina, Jorge G Gomez-Gutierrez, Humberto Rodriguez-Rocha, Yolanda Gutierrez-Puente, Odila Saucedo-Cardenas, Jesus Valdes-Flores, Roberto Montes-de-Oca-Luna
Primary Institution: Universidad Autónoma de Nuevo León (UANL)
Hypothesis
Can Lactococcus lactis be genetically modified to produce and secrete biologically active IP-10?
Conclusion
Lactococcus lactis can efficiently produce and secrete biologically active IP-10, making it a potential tool for cancer therapy.
Supporting Evidence
- The recombinant strain of Lactococcus lactis secreted IP-10 into the culture medium.
- Western blot analysis confirmed the presence of biologically active IP-10.
- The NICE system allowed for continued expression of IP-10 even after nisin removal.
Takeaway
Scientists made a special version of a bacteria that can create a helpful protein called IP-10, which can attract immune cells to fight diseases.
Methodology
The IP-10 gene was cloned into Lactococcus lactis, and its secretion was analyzed using Western blot and chemotaxis assays.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website